Livedoid Pattern in the Abdomen of a Patient with Myelofibrosis: A Quiz
DOI:
https://doi.org/10.2340/actadv.v101.277Keywords:
Reactive angioendotheliomatosis, myelofibrosis, prothrombotic, livedoid patternAbstract
Abstract is missing (Quiz)
Downloads
References
McMenamin MC, Fletcher CD. Reactive angioendotheliomatosis a study of 15 cases demonstrating a wide clinicopathologic spectrum. Am J Surg Pathol 2002; 26: 685-697.
https://doi.org/10.1097/00000478-200206000-00001 DOI: https://doi.org/10.1097/00000478-200206000-00001
Singer C, Mallon D, Auguston B, Lam M, Foster R. Reactive angioendotheliomatosis presenting as livedo racemosa secondary to propylthiouracil. Pathology 2020; 52: 494-496.
https://doi.org/10.1016/j.pathol.2020.03.006 DOI: https://doi.org/10.1016/j.pathol.2020.03.006
Lazova R, Slater C, Scott G. Reactive angioendotheliomatosis. Case report and review of the literature. Am J Dermatopathol 1996; 18: 63-69.
https://doi.org/10.1097/00000372-199602000-00010 DOI: https://doi.org/10.1097/00000372-199602000-00010
Thai K, Barrett W, Kossard S. Reactive angioendotheliomatosis in the setting of antiphospholipid syndrome. Australas J Dermatol 2010; 44: 151-155.
https://doi.org/10.1046/j.1440-0960.2003.00670.x DOI: https://doi.org/10.1046/j.1440-0960.2003.00670.x
Di Filippo Y, Cardot-Leccia N, Long-Mira E, Andreani M, Richez V, Lacour JP, et al. Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide. J Eur Acad Dermatol Venereol 2021; 35: 115-118.
https://doi.org/10.1111/jdv.16840 DOI: https://doi.org/10.1111/jdv.16840
Mazloom SE, Stallings A, Kyei A. differentiating intralymphatic histiocytosis, intravascular histiocytosis, and subtypes of reactive angioendotheliomatosis: review of clinical and histologic features of all cases reported to date. Am J Dermatopathol 2017; 39: 33-39.
https://doi.org/10.1097/DAD.0000000000000574 DOI: https://doi.org/10.1097/DAD.0000000000000574
Kirke S, Angus B, Kesteven PJ, Calonje E, Simpson N. Localized reactive angioendotheliomatosis. Clin Exp Dermatol 2007; 32: 45-47.
Harrison C, Kiladjian JJ, Al-Ali HK, Gisslinger H, Waltzman R, Stalbovskaya V, et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med 2012; 366: 787-798.
https://doi.org/10.1056/NEJMoa1110556 DOI: https://doi.org/10.1056/NEJMoa1110556
Gangat N, Tefferi A. Myelofibrosis biology and contemporary management. Br J Haematol 2020; 191: 152-170.
https://doi.org/10.1111/bjh.16576 DOI: https://doi.org/10.1111/bjh.16576
Ponzoni M, Campo E, Nakamura S. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood 2018; 132: 1561-1567.
https://doi.org/10.1182/blood-2017-04-737445 DOI: https://doi.org/10.1182/blood-2017-04-737445
Perniciaro C, Winkelmann RK, Daoud MS, Su WP. Malignant angioendotheliomatosis is an angiotropic intravascular lymphoma. Immunohistochemical, ultrastructural, and molecular genetics studies. Am J Dermatopathol 1995; 17: 242-248.
https://doi.org/10.1097/00000372-199506000-00005 DOI: https://doi.org/10.1097/00000372-199506000-00005
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Diego Soto-García, Gonzalo Peón, Carlos Álvarez, Carmen Couselo-Rodríguez, Ángelez Flórez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
